Pharmacologic Therapies to Prevent Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Relapse is the main cause of mortality in patients with acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Adverse cytogenetic or molecular risk factors, as well as refractory disease or persistent measurable residual disease (MRD) at the time of trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Antar, Ahmad I., Otrock, Zaher K., Abou Dalle, Iman, El-Cheikh, Jean, Bazarbachi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667262/
https://www.ncbi.nlm.nih.gov/pubmed/33224890
http://dx.doi.org/10.3389/fonc.2020.596134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667262/
https://www.ncbi.nlm.nih.gov/pubmed/33224890
http://dx.doi.org/10.3389/fonc.2020.596134

Ejemplares similares